Dr. Saima Aslam MD, MS

Professor of Medicine
Medical Director, Solid Organ Transplant Infectious Diseases
Division of Infectious Diseases and Global Public Health
University of California, San Diego

Dr. Aslam is Professor of Medicine and Director of the Solid Organ Transplant Infectious Diseases service at the University of California San Diego (UCSD). She is focused on providing both excellent clinical care of transplant candidates and recipients as well as clinical and translational research. She developed multiple innovative clinical practice protocols aimed at increasing the transplant rate at UCSD with excellent clinical outcomes. These include protocols for the use of HCV-viremic organ donors as well as those with COVID-19; she also expanded the type of candidates listed for transplant including those that are infected with COVID-19 and HIV. She is a leader on the national and international transplantation stage, having several leadership positions in the International Society of Heart and Lung Transplantation, the American Society of Transplantation and the Disease Transmission Advisory Committee of United Network for Organ Sharing. Dr Aslam is a lead or co-author in several international transplantation related guidelines, an invited speaker at many national and international meetings, and has >90 peer-reviewed publications.

Dr Aslam graduated with honors from the Aga Khan University in Pakistan in 1999 and then trained at Baylor College of Medicine, Texas in Internal Medicine and Infectious Diseases. She received a Master of Science in Clinical Investigation from Baylor College of Medicine (BCM) in 2008 and a certificate from the Health Leadership Academy at UCSD in 2020. She was faculty at BCM until 2010 when she moved to UCSD with an NIH-funded K-award, at which she also initiated the Transplant Infectious Diseases service at that time. Dr. Aslam has been involved in education within UCSD in several leadership roles as well: member of the Executive Committee for the MAS in Clinical Research at UCSD from 2014-2019 and Chair of the Admissions committee for the MAS program during this time as well.

Dr Aslam is active in many NIH, Cystic Fibrosis Foundation, and pharma funded clinical trials either as study Principal Investigator (PI) or as the lead UCSD Site PI. These are collaborative multicenter clinical trials including three ongoing studies investigating the use of HIV+ organ donors for kidney and liver transplantation as well as several studies investigating the use of bacteriophage-based therapeutics. She has also been invited as a thought leader to several NIH workshops focused on expanding the impact of HIV and HCV organ transplantation as well as phage therapeutics.

Dr. John W BaddleyMD, MSPH, FIDSA, FAST

Professor of Medicine, Division of Infectious Diseases
University of Maryland School of Medicine

John W. Baddley, MD, MSPH is a Professor of Medicine in the Division of Infectious Diseases at the University of Maryland School of Medicine. He serves as Director, Immunocompromised Host ID Section. He previously served as Director, Transplant Infectious Diseases at University of Alabama at Birmingham’s Comprehensive Transplant Institute. His clinical work focuses on management of infections in the immunocompromised host. In addition to his clinical and teaching work, Dr. Baddley participates in clinical trials and outcomes research. Dr. Baddley currently serves as President elect of The Transplantation Society’s Transplant ID Section and as an Associate Deputy Editor of Open Forum Infectious Diseases.

Dr. Emily Blumberg, MD

Emily Blumberg, MD is a Transplant Infectious Diseases specialist and the Director of the Transplant Infectious Diseases Program and the Infectious Diseases Fellowship at the University of Pennsylvania. She is a Deputy Editor for the American Journal of Transplantation. She served as AST President from 2019-2020 and currently serves on the United Network of Organ Sharing/Organ Procurement and Transplantation Network Board of Directors. Dr. Blumberg's academic interests focus on infectious disease complications in transplant recipients and candidates. She is especially interested in donor derived infections and viral infections, including HIV, CMV, HCV and COVID-19.

Dr. Jose F Camargo MD

Associate Professor of Clinical Medicine, Division of Infectious Diseases Immunocompromised Host (Transplant/Oncology) Section, University of Miami Miller School of Medicine

Dr. Jose F Camargo is a Transplant Infectious Diseases specialist with 10 years of experience. He completed a post-doctoral research fellowship in immunogenetics at the University of Texas Health Science Center in San Antonio; and underwent Internal Medicine training at Jacobi Medical Center/Albert Einstein College of Medicine in New York; followed by an Infectious Diseases fellowship at Westchester Medical Center/New York Medical College, and a Transplant Infectious Diseases fellowship at the University of Toronto. Currently, he is an Associate Professor of Medicine, Immunocompromised Host Section, Division of Infectious Diseases at the University of Miami, Miller School of Medicine. His research interests include CMV and Aspergillus infections, vaccine immunogenicity, and cell-mediated immunity.

Lara Danziger-Isakov MD, MPH (she/her)

Professor of Pediatrics
Interim Director, Infectious Disease
Director, Immunocompromised Host Infectious Diseases
Cincinnati Children's Hospital Medical Center
University of Cincinnati

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is a Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and completed her fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on epidemiology and vaccination. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new methods of detection for infectious diseases.

Dr. Laura Donahoe

Medical Director, Medical Device Reprocessing Department
Program Director, Division of Thoracic Surgery
Assistant Professor, Department of Surgery
University of Toronto

Laura Donahoe completed her undergraduate degree in Health Sciences at McMaster University and received her M.D. from Queen's University. She did general surgery training at Dalhousie University and thoracic surgery training at the University of Toronto, with a one-year fellowship specializing in CTEPH, mesothelioma, and lung transplantation. She also completed an MSc in Health Sciences Education at McMaster University. Her research interests are varied and include surgical education, specifically technical skill simulation and assessment, and clinical outcomes in transplant, CTEPH, and germ cell tumors.

Melissa Gitman

Assistant Professor, Department of Pathology, Molecular and Cell-Based Medicine
Icahn School of Medicine at Mount Sinai

Melissa Gitman, MD, MPH is the medical director of the clinical microbiology laboratory at Mount Sinai Hospital in New York City. She graduated from McGill University Faculty of Medicine and earned a master’s degree at the Harvard School of Public Health. Melissa completed training in internal medicine infectious diseases, and medical microbiology prior to completing Transplant ID fellowship at UHN. Her research interests include antimicrobial resistance, diagnostics in the immunocompromised host population and finding ways to improve communication between patient facing providers and the microbiology laboratory.

Dr. Ghady Haidar M.D.

Assistant Professor of Medicine
Division of Infectious Diseases, Transplant ID Program
Director of Research, Bone Marrow Transplant/Hematologic Malignancy ID
Program Director, Transplant ID Fellowship
University of Pittsburgh and UPMC

Ghady Haidar MD is an Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Pittsburgh, and a Transplant ID physician at UPMC. He is the Program Director for the Transplant ID Fellowship, and Director of Research for the Hematological Malignancy ID Program. He receives funding from NIH and industry to study infections in immunocompromised individuals. As a physician-investigator, he is actively involved in clinical and translational research with a focus on infectious in immunocompromised patients. His main research interests are optimizing the treatment and prevention of SARS-CoV-2 infection in immunocompromised individuals and advancing our understanding of bacteriophage therapy for infections caused by drug-resistant bacteria through bench-to-bedside approaches. Dr. Haidar also attends on the inpatient transplant infectious diseases (organ transplant and hematological cancer) services at UPMC.

Dr. Sasan HosseiniMD, MSc, MPH

Associate Professor of Medicine
Transplant-Oncology Infectious Diseases, Fellowship Director
Division of Infectious Diseases, Fellowship Director
Department of Medicine, University of Toronto
University Health Network

Dr. Sasan Hosseini is a Specialist of Infectious Diseases and Tropical Medicine, Fellowship in Transplant Infectious Diseases, U of T, has a MSc degree in Public Health and Epidemiology and Biostatistics. ICES Scientist, from 2014-219 was a Transplant ID Medical Director: London Health Sciences Centre, UWO, from 2021 to present is a Transplant ID, Fellowship Director, Ajmera Transplant Centre, UHN and Infectious Diseases Division, Fellowship Director, Dept. of Medicine, U of T.

Dr. Atul Humar MD

Professor, Department of Medicine
University of Toronto
Director, Ajmera Transplant Centre
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada

Atul Humar is a professor in the Department of Medicine at the University of Toronto in Toronto, Canada. He is Director of the Transplant Institute at the University of Toronto and Director of the University Health Network Ajmera Transplant Centre. Dr Humar received his medical degree from the University of Ottawa in Ottawa, ON. He completed his residency and further training in transplant infectious diseases in Toronto and Boston.

Dr Humar’s research interests are in virology with a focus on the pathogenesis of herpesvirus infections post-transplant. He is involved in both basic and clinical research assessing immunologic and virologic determinants of infection. His work was integral to the development of internationally used guidelines related to the management of infections post-transplant. He is past-President of the Canadian Society of Transplantation.

Dr. Camille Nelson Kotton

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Associate Professor, Harvard Medical School

Camille Nelson Kotton, MD, FIDSA, FAST, is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and an associate professor of medicine at Harvard Medical School in Boston, MA.

Dr. Kotton’s clinical interests include cytomegalovirus, vaccines, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. She is a member of the CDC Advisory Committee on Immunization Practices (ACIP) and is involved in national decisions regarding COVID-19 and other vaccines.

Dr. Kotton has served as the chair of The Infectious Disease Community of Practice of The American Society of Transplantation. She has also served as the president of The Transplant Infectious Disease Section of The Transplantation Society and highlights of her time as president include the development of 3 versions of the international guidelines on CMV management after solid organ transplant, published in Transplantation. She is the first transplant infectious disease specialist to be a councilor of The Transplantation Society.

Dr. Me-Linh Luong

Microbiologiste infectiologue
Professeure agrégé de clinique
Microbiologie médicale et infectiologie
CHUM

Me-Linh Luong, MD is an associate professor at the University of Montreal. Dr. Luong completed her MD training at the University of Sherbrooke, a fellowship training in Infectious Diseases and Medical Microbiology at McGill University followed by specialized training in Transplant Infectious Diseases at the University of Toronto. She joined the University of Montreal as faculty in 2011 where she instructs medical students, residents, and fellows.

Her expertise is in caring for solid-organ transplant candidates and recipients as well as other immunocompromised individuals. Dr. Luong directs the CHUM Transplant Infectious Diseases Service, which provides expert care in the prevention and management of infectious diseases in organ transplant donors and recipients. Her research focuses on the risk factors and outcomes of infections in solid organ transplant recipients. She has a special interest in fungal infections of immunocompromised hosts.

Dr.Tony Mazzulli MD, FRCPC, FACP

Department of Microbiology, Sinai Health/University Health Network; Department of Laboratory Medicine and Pathobiology, University of Toronto

Dr. Tony Mazzulli is the Microbiologist-in-Chief and Infectious Diseases Specialist at Sinai Health and University Health Network, and a consulting Medical Microbiologist for the Public Health Ontario Laboratories. He is a Professor in the Department of Laboratory Medicine and Pathobiology, Faculty of Medicine at the University of Toronto. In addition, he is the Program Director for the Medical Microbiology Residency Training Program and the Postdoctoral Clinical Microbiology Training Program, Faculty of Medicine, University of Toronto, the President of the Canadian Association for HIV Clinical Laboratory Specialists (CAHCLS), and the Chair of the Royal College of Physicians and Surgeons of Canada Medical Microbiology Subspecialty Committee. He has published over 200 articles in peer reviewed medical/scientific journals and 5 book chapters.

Dr. Yoichiro Natori MD, M.P.H.

Director of Solid Organ Transplant Infectious Diseases, Miami Transplant Institute, Jackson Health System, Miami, Florida, USA

Associate Professor of Clinical Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA

Dr. Natori was born in Japan and earned his medical degree from Nagoya University School of Medicine. He completed his residency and infectious disease fellowship at St. Luke's International Hospital in Tokyo, Japan. Additionally, he finished his Transplant Infectious Disease fellowship at the University Health Network, University of Toronto. Currently, Dr. Natori serves as a faculty member in the Division of Infectious Diseases at the Department of Clinical Medicine at the University of Miami Miller School of Medicine. He also holds the position of medical director of Solid Organ Transplant Infectious Diseases at the Miami Transplant Institute, Jackson Health System.

Dr. Raymund Razonable MD

Professor of Medicine, Program Director and Vice Chair, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota

Raymund R. Razonable, MD, is Professor of Medicine and Distinguished Clinician at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota. He serves as the Vice Chair of the Division of Public Health, Infectious Diseases and Occupational Medicine, and Program Director of the Infectious Diseases Fellowship Training Programs at the Mayo Clinic.

Dr. Razonable's clinical, educational and research interests focus on infections related to or gan transplantation, including cytomegalovirus infections. He has authored over 300 peer-reviewed original and review articles, more than 30 book chapters and over 200 abstracts on these topics. He serves as one of the editors of Transplant Infectious Diseases journal, and a member of the Board of Directors of the American Society of Transplantation.

Dr. Coleman RotsteinMD, FRCPC, FACP, FIDSA, FAMMI

Dr. Rotstein is Professor of Medicine in the Division of Infectious Diseases at the University of Toronto and Attending Physician at the University Health Network, Toronto, Ontario. He received a Bachelor of Science at the University of Toronto and earned his medical degree from the University of Calgary in 1976. Dr. Rotstein completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston, South Carolina from 1980 to 1983 [ABIM (1980), FRCPC (Internal Medicine 1981), Infectious Diseases ABIM (1982)].

Dr. Rotstein is currently the Director of Oncologic Infectious Diseases of the Immunocompromised Host Infectious Diseases Service at the University Health Network. He was a member of the Board of the Canadian Foundation for Infectious Diseases until 2021 and the Past Chair of the Awards Committee of the Foundation. Dr. Rotstein was also a member of the National Advisory Committee on Immunization of the Public Health Agency of Canada from 2017-2021. In addition, he has been elected a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is also a fellow of the European Confederation of Medical Mycology. He functions as a reviewer for several international journals.

Dr. Rotstein has published over 195 peer-reviewed papers. His research interests have focused mainly on infections in cancer patients and other immunocompromised hosts.

Dr. Chaya ShwaartzMD

Assistant professor, Department of General Surgery, University of Toronto
Abdominal Transplant & HPB Surgical Oncology

Dr. Chaya Shwaartz is an assistant Professor in the Division of General Surgery at UHN and the Department of Surgery. She completed her fellowship in Abdominal Transplant and HPB surgical oncology was done at U of T, Toronto General Hospital.

Dr. Shwaartz main interests are minimally invasive surgery and surgical education. She is codirector of the Abdominal Transplant and Hepatobiliary Surgery fellowship at the University of Toronto.

Dr. Sarah ShalhoubMBBS

Assistant Professor of Medicine
Division of Infectious Diseases
Western University

Sarah Shalhoub, MBBS is the clinical director of the Transplant Infectious Diseases service in the Infectious Diseases Division at London Health Sciences Center, and an Assistant Professor of Medicine at Western University, London, Ontario.

She is the director of the Transplant Infectious Diseases Fellowship program at the Multiorgan Transplant Department, London Health Sciences Center.

Her research interests include infection outcomes in solid organ transplant recipients and patients with hematological malignancies.

Dr. Miranda SoPharmD MPH

Antimicrobial Stewardship Program Lead-UHN and Research Director, SH-UHN ASP
Assistant Professor (Status), Leslie Dan Faculty of Pharmacy, University of Toronto
Clinician Investigator, Toronto General Hospital Research Institute

Dr. Miranda So received her Doctor of Pharmacy (PharmD) degree from the University of Toronto, and her Master of Public Health (MPH) degree from the Harvard T.H. Chan School of Public Health, Harvard University. Miranda is an Assistant Professor (Status) at the Leslie Dan Faculty of Pharmacy, University of Toronto and a Clinician-Investigator with the Toronto General Hospital Research Institute. An established antimicrobial stewardship pharmacist, Miranda has over a decade of clinical and research experience in antimicrobial stewardship at the region and institutional levels, as well as surveillance of antimicrobial use in hospitals across Canada. Miranda is currently the Antimicrobial Stewardship Program Lead at the University Health Network in Toronto Canada, part of the joint Sinai Health-UHN Antimicrobial Stewardship Program, in addition to being the program’s Research Director. Miranda specializes in antimicrobial stewardship for immunocompromised patients—patients with haematological malignancies, recipients of stem cell transplant and solid organ transplant.